Samer Al Hadidi, Assistant Professor at UAMS Myeloma Center, made the following post on X:
“This is an updated results data of BCMA CAR-T and BCMA BsAb with updated data from recent presentations/publications based on few requests I got
Updated data for Elranatamab looks great
In areas with equal access to CAR-T: no role for ide cel
Excellent BsAb data.”
Source: Samer Al Hadidi/X